This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

New regulatory challenges could hit India's M&A review timelines

By Freny Patel ( February 21, 2025, 00:37 GMT | Comment) -- Mergers and acquisitions face stricter scrutiny and potentially longer approval timelines after India's top court, in a recent judgment, criticized the antitrust watchdog's processes. The Supreme Court of India in its AGI Greenpac-Hindustan National Glass & Industries ruling last month challenged the Competition Commission of India's merger review process. The court's interpretation of "parties to the combination" could be detrimental to hostile takeovers and insolvency matters. Also, mandating public scrutiny of remedies after the issuance of show-cause notices could potentially increase M&A timelines and costs.Mergers and acquisitions face stricter scrutiny and potentially longer approval timelines after India's top court, in a recent judgment, criticized the antitrust watchdog's processes....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections